Adjuvant chemotherapy may have no significant survival benefit in older patients with stage II/III gastric cancer: a multicenter retrospective study

Abstract Aim Postoperative adjuvant chemotherapy is known to enhance cure rates and is thus recommended for stages pII to pIII. However, specific guidelines for such treatment in elderly gastric cancer (GC) patients are currently lacking. This study examines the impact of adjuvant chemotherapy on th...

Descrición completa

Detalles Bibliográficos

Principais autores:	Zheng-Zheng Shen, En-Ze Li, Ruo-Lan Zhang, Meng-Xuan Cao, Yan-Qiang Zhang, Qing Yang, Can Hu, Si-Wei Pan, Zhi-Yuan Xu, Zai-Sheng Ye, Jing-Yang He
Formato:	Artigo
Idioma:	Inglês
Publicado:	Springer 2025-05-01
Series:	Journal of Cancer Research and Clinical Oncology
Assuntos:	Gastric cancer Adjuvant chemotherapy Elderly patients
Acceso en liña:	https://doi.org/10.1007/s00432-025-06230-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!